Boji Medical Technology Co Ltd
SZSE:300404
Boji Medical Technology Co Ltd
SZSE:300404
Price:
10.56
CNY
-1.31%
Market Closed
Market Cap:
¥4.1B
Relative Value
The Relative Value of one
Boji Medical Technology Co Ltd
stock under the Base Case scenario is
7.35
CNY.
Compared to the current market price of 10.56 CNY,
Boji Medical Technology Co Ltd
is
Overvalued by 30%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Relative Value
Base Case
7.35
CNY
Overvaluation 30%
Multiples Across Competitors
Competitors Multiples
Boji Medical Technology Co Ltd Competitors
Boji Medical Technology Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
|
Boji Medical Technology Co Ltd
SZSE:300404
|
4B CNY | 5.3 | 546.1 | 786.5 | 786.5 | |
| US |
P
|
PerkinElmer Inc
LSE:0KHE
|
1.1T USD | 375.4 | 4 444.8 | 1 409.2 | 3 011 | |
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
191.7B USD | 4.3 | 28.7 | 20 | 26.9 | |
| US |
|
Danaher Corp
NYSE:DHR
|
148.4B USD | 6.1 | 41.2 | 22.8 | 34.7 | |
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
79.2T KRW | 8.4 | 29 | 29.1 | 38.8 | |
| CH |
|
Lonza Group AG
SIX:LONN
|
36.8B CHF | 5.7 | 39.3 | 28.8 | 28.8 | |
| CN |
|
WuXi AppTec Co Ltd
SSE:603259
|
291.5B CNY | 6.6 | 19.4 | 19.7 | 19.7 | |
| US |
|
Agilent Technologies Inc
NYSE:A
|
34.7B USD | 5 | 26.6 | 19.4 | 23 | |
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
28.2B USD | 1.7 | 20.6 | 11.6 | 17.4 | |
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
28.1B USD | 7 | 32.3 | 23.8 | 26.5 | |
| CN |
|
WuXi Biologics (Cayman) Inc
HKEX:2269
|
164.6B HKD | 7.3 | 34.7 | 24.4 | 24.4 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
